Technavio has been monitoring the global lifestyle drugs market, which is expected to grow by USD 4.85 billion accelerating at a CAGR of almost 3% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. Download latest version with COVID-19 analysis Free Sample Report
This report provides a detailed analysis of the lifestyle drugs market by therapy area (Depression, Dermatology, Sexual dysfunction, and Obesity) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024. The report also provides a detailed analysis of around 25 vendors operating in the lifestyle drugs market.
Lifestyle Drugs Market: Segmentation by Therapy Area
During 2019, the depression therapy segment accounted for the major share of the Lifestyle Drugs Market. Depression is the most common mental disorder worldwide, which contributes significantly to the global burden of diseases. This report provides an accurate prediction of the contribution of all the segments to the growth of the lifestyle drugs market market size.
Lifestyle Drugs Market: Segmentation by Geography
North America was the largest Lifestyle Drugs Market market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. Market growth in this region will be slower than the growth of the market in other regions.
Lifestyle Drugs Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., AstraZeneca Plc and Bristol-Myers Squibb Co. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio offers custom research reports with detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19 Download a Free Sample Report
